|
Patient- and Physician-Based Osteoporosis Education Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, trips or treatment by using a genuine doctor. We aren't doctors. Always consult your mD on Patient- and Physician-Based Osteoporosis Education conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Patient- and Physician-Based Osteoporosis Education Clinical research trials and Patient- and Physician-Based Osteoporosis Education health trials take place in a lot of of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / projects is to answer specific human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, like Patient- and Physician-Based Osteoporosis Education. Patient- and Physician-Based Osteoporosis Education Clinical Trials and other clinical trials allow for volunteers to have health treatment alternatives before they are available to the general public. Many times the test subjects obtain treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Patient- and Physician-Based Osteoporosis Education clinical trial. Subjects oftentimes recieve the most effective healthcare possible for their Patient- and Physician-Based Osteoporosis Education condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Patient- and Physician-Based Osteoporosis Education  Patient- and Physician-Based Osteoporosis Education
Patient- and Physician-Based Osteoporosis Education
For Condition: Osteoporosis,Osteoporosis, Postmenopausal
Status: No longer recruiting
Sponsor(s): National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) , Arthritis Foundation
Synopsis: Osteoporosis is an important public health problem. Osteoporosis can cause serious health complications and death and leads to increased medical costs. The purpose of this study is to identify an effective method of educating patients and health care professionals about the diagnosis and treatment of osteoporosis.
Details: Osteoporosis affects a large and growing proportion of the population. Multiple drugs for the prevention and treatment of osteoporosis have been developed, tested, and proven effective in the last decade. However, these drugs may not always be adequately prescribed. Several effective nonpharmacological measures also exist for preventing fractures; strength and gait training, home safety modifications, and other lifestyle modifications have all been shown in carefully conducted trails to reduce the risk of falls that lead to osteoporotic factures. Yet these interventions are under-utilized. Practical public health strategies are needed to bring these experimental findings to widespread use in typical populations of at-risk patients. This study will evaluate innovative fracture prevention interventions targeted to both patients and doctors. Specifically, the study will compare the effects of the patient and physician behavior change intervention alone and in combination on prescribing patterns for osteoporosis therapies and will examine the interventions' effects on fracture prevention behaviors other than medication use. The patient intervention will consist of two mailings and will be targeted using clinical and demographic data from the State of Pennsylvania's Pharmaceutical Assistance Contract for the Elderly (PACE) and Medicare databases. The first mailing will introduce the topic of osteoporosis and explain why osteoporosis is an important topic for all those receiving the mailing. The second mailing, sent the following month, will reinforce the first mailing and contain patient-specific information based on demographic and clinical factors. This mailing will also focus on several proven prevention strategies, including strength and gait training, vision care, home safety improvements, calcium intake, and pharmaceutical enhancement of bone density. The physician intervention will be multifaceted and will include a mailed practice audit and one-on-one education through academic detailing. The mail audit will contain information on the physician’s PACE patients and an assessment of their osteoporosis risk based on clinical and drug data. Following the mailing, an academic detailer will meet with the physicians receiving the intervention. Outcome measures will include questionnaires, medication use, Dual Energy X-ray Absorptiometry (DEXA) scans, and use of physical therapy.
Eligibility:
Study Type: Interventional, Educational/Counseling/Training, Randomized, Single Blind, Active Control, Factorial Assignment, Efficacy Study
Minimum Age/Maximum Age: 65 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria For Patients: - PACE beneficiaries who filled at least one prescription for a drug of any type in the year prior to the study - At high risk for osteoporosis: women and men 75 years or older, patients taking glucocorticoids or psychoactive medications, patients diagnosed with rheumatoid arthritis, and patients with a past fracture - Have had an outpatient visit with a participating doctor based on Medicare outpatient claims Inclusion Criteria For Physicians: - Primary prescribing physicians for PACE beneficiaries
Total Enrollment: 30000
Location and Contact Information:
Overall Study Official:
DanielSolomon, Principal Investigator,
Daniel H. Solomon MD, MPH
Boston, Massachusetts, 02115
United States
Additional Information:
Study ID Numbers: NIAMS-074; K23 AR48616
Study Start Date: September 2003
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00073190
Other Osteoporosis, Postmenopausal Studies:
1. Study of Low Bone Mass in Premenopausal or Perimenopausal Women
2. Building Better Bones in Children
3. Parathyroid Hormone (PTH) with Alendronate for Osteoporosis
4. Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
5. Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients with Prostate Cancer
Related Studies:
Other Osteoporosis, Postmenopausal Clinical Trials
Other Massachusetts Clinical Trials
Other Boston Clinical Trials
Patient- and Physician-Based Osteoporosis Education
|
|
|
|
|
|
|
|
